12.2 C
Canberra
Wednesday, April 17, 2024

Medicaid Protection and Reimbursement of Antiobesity Medicines throughout States – Healthcare Economist






Medicaid insurance policies fluctuate from state-to-state. With the arrival of latest, GLP-1 drugs (and others) to deal with weight problems and obese, there are doubtlessly vital well being advantages to be gained. Nonetheless, are State Medicaid Businesses truly protecting these drugs? That is the query requested by Liu et al. (2024). They use knowledge from public state Medicaid formulary and most well-liked drug record recordsdata to find out if a state lined FDA-approved anti-obesity drugs. The variety of reimbursed prescriptions for every antiobesity remedy was recognized from public 2011-2022 Medicaid State Drug Utilization knowledge.

Basically, some however not all anti-obesity drugs are lined. Furthermore, the simpler GLP-1 drugs are usually solely lined if they’re used to deal with diabetes (somewhat than obese or weight problems).

Within the first quarter of 2023, 10 of 47 states (21%) with public most well-liked drug lists lined a minimum of 1 antiobesity remedy; 5 (11%) had unrestricted protection of a minimum of 1 antiobesity remedy…Individually, 39 states (83%) had unrestricted protection of a minimum of 1 of the two diabetes variations of GLP-1 RAs.

https://jamanetwork.com/journals/jama/fullarticle/2816585

The complete article is right here.



Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles